Profitability
Weight: 25%
F
5
- 5yr Avg ROIC -11.3%
- Operating Margin Trend -1.23 pp/yr
TXG
10x Genomics, Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.
Grade overrides the 29.7 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
7
- 5yr Avg ROE -17.7%
- 5yr Share-Count CAGR 3.1%
Growth Quality
Weight: 25%
C
54
- 5yr Revenue CAGR 7.0%
- 5yr EPS CAGR 0.0%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
F
0
- 5yr FCF Margin -9.6%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 10%
A+
100
- Net Debt / EBITDA -93.55x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 15.50
Stability
Weight: 5%
B+
78
- EPS Volatility (σ/μ) 0.00
- Piotroski F-Score 4
- Negative-Revenue Years (5) 1/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.3 of 3 gurus held; 1 added; 2 trimmed.
- Holders
- 3
- Avg Δ position
- -39.9%
- New buys
- 0
- Full exits
- 0
- Dalio decreased -80%
- Cooperman decreased -61%
- Greenblatt increased +21%